Design and in vitro evaluation of simvastatin-hydroxyapatite coatings by an electrochemical process on titanium surfaces

Journal of Biomedical Nanotechnology

Volumn 10, Issue 7, 2014, Pages 1313-1319

  Shifang, Zhao ^a   Jue, Shi ^a   Fuming, He ^a   Liu, Li ^a   Guoli, Yang ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Electrochemical process; Hydroxyapatite; Osteoblast; Simvastatin; Titanium

Indexed keywords

CELL PROLIFERATION; HYDROXYAPATITE; OSTEOBLASTS; PHOSPHATASES; TITANIUM;

ALKALINE PHOSPHATASE ACTIVITY; ELECTROCHEMICAL PROCESS; ENHANCED DIFFERENTIATIONS; IN-VITRO EVALUATION; OSTEOBLASTIC ACTIVITY; OSTEOPROGENITOR CELLS; SIMVASTATIN; SURFACE CHARACTERISTICS;

COATINGS;

ALKALINE PHOSPHATASE; HYDROXYAPATITE; OSTEOCALCIN; SIMVASTATIN; TITANIUM; BIOMATERIAL; DNA;

ANIMAL CELL; ARTICLE; CALVARIA; CELL ACTIVITY; CELL PROLIFERATION; CONTROLLED STUDY; CRYSTAL; DRUG COATING; ELECTROCHEMISTRY; ENZYME ACTIVITY; FIELD EMISSION SCANNING ELECTRON MICROSCOPY; IN VITRO STUDY; INCUBATION TIME; INFRARED SPECTROSCOPY; LIQUID CHROMATOGRAPHY; NONHUMAN; OSTEOBLAST; OSTEOPROGENITOR CELL; PROTEIN SECRETION; SURFACE PROPERTY; TANDEM MASS SPECTROMETRY; X RAY DIFFRACTION; ANIMAL; CELL LINE; CYTOLOGY; DRUG EFFECTS; ELECTROCHEMICAL ANALYSIS; ENZYMOLOGY; MATERIALS TESTING; METABOLISM; MOUSE; POROSITY; PROCEDURES; SCANNING ELECTRON MICROSCOPY; SECRETION (PROCESS);

ALKALINE PHOSPHATASE; ANIMALS; CELL LINE; CELL PROLIFERATION; COATED MATERIALS, BIOCOMPATIBLE; DNA; DURAPATITE; ELECTROCHEMICAL TECHNIQUES; MATERIALS TESTING; MICE; MICROSCOPY, ELECTRON, SCANNING; OSTEOBLASTS; OSTEOCALCIN; POROSITY; SIMVASTATIN; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SURFACE PROPERTIES; TITANIUM; X-RAY DIFFRACTION;

EID: 84899045713     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2014.1859     Document Type: Article

References (30)

1. Y. Ayukawa, E. Yasukawa, Y. Moriyama, Y. Ogino, H. Wada, I. Atsuta, and K. Koyano, Local application of statin promotes bone repair through the suppression of osteoclasts and the enhancement of osteoblasts at bone-healing sites in rats. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 107, 336 (2009).
2. D. Buser, R. K. Schenk, S. Steinemann, J. P. Fiorellini, C. H. Fox, and H. Stich, Influence of surface characteristics on bone integration of titanium implants. A histomorphometric study in miniature pigs. J. Biomed. Mater. Res. 25, 889 (1991).
3. C. J. Edwards, D. J. Hart, and T. D. Spector, Oral statins and increased bone-mineral density in postmenopausal women. Lancet 355, 2218 (2000).
4. J. L. Goldstein and M. S. Brown, Regulation of the mevalonate pathway. Nature 343, 425 (1990).
5. X. Guo, J. E. Gough, P. Xiao, J. Liu, and Z. Shen, Fabrication of nanostructured hydroxyapatite and analysis of human osteoblastic cellular response. J. Biomed. Mater. Res. A 82, 1022 (2007).
6. N. Horiuchi and T. Maeda, Statins and bone metabolism. Oral Dis. 12, 85 (2006).
7. R. Hwang, E. J. Lee, M. H. Kim, S. Z. Li, Y. J. Jin, Y. Rhee, Y. M. Kim, and S. K. Lim, Calcyclin, a Ca2+ ion-binding protein, contributes to the anabolic effects of simvastatin on bone. J. Biol. Chem. 279, 21239 (2004).
8. H. Imaizumi, M. Sakurai, O. Kashimoto, T. Kikawa, and O. Suzuki, Comparative study on osteoconductivity by synthetic octacalcium phosphate and sintered hydroxyapatite in rabbit bone marrow. Calcif Tissue Int. 78, 45 (2006).
9. R. Junker, A. Dimakis, M. Thoneick, and J. A. Jansen, Effects of implant surface coatings and composition on bone integration: A systematic review. Clin. Oral Implants Res. 20, 185 (2009).
10. W. H. Kaesemeyer, R. B. Caldwell, J. Huang, and R. W. Caldwell, Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions. J. Am. Coll. Cardiol. 33, 234 (1999).
11. H. W. Kim, Y. H. Koh, L. H. Li, S. Lee, and H. E. Kim, Hydroxyapatite coating on titanium substrate with titania buffer layer processed by sol-gel method. Biomaterials 25, 2533 (2004).
12. K. H. Kim and N. Ramaswamy, Electrochemical surface modification of titanium in dentistry. Dent. Mater. J. 28, 20 (2009).
13. U. Laufs, V. L. Fata, and J. K. Liao, Inhibition of 3-hydroxy-3- methylglutaryl (HMG)-CoA reductase blocks hypoxia-mediated down-regulation of endothelial nitric oxide synthase. J. Biol. Chem. 272, 31725 (1997).
14. Y. Lou, H. Hu, Y. Liu, Q. Yu, L. Li, L. Ping, L. Yu, H. Jiang, and S. Zeng, Determination of chamaechromone in rat plasma by liquid chromatography-tandem mass spectrometry: Application to pharmacokinetic study. J. Pharm. Biomed. Anal. 55, 1163 (2011).
15. T. Maeda, T. Kawane, and N. Horiuchi, Statins augment vascular endothelial growth factor expression in osteoblastic cells via inhibition of protein prenylation. Endocrinology 144, 681 (2003).
16. T. Maeda, A. Matsunuma, I. Kurahashi, T. Yanagawa, H. Yoshida, and N. Horiuchi, Induction of osteoblast differentiation indices by statins in MC3T3-E1 cells. J. Cell Biochem. 92, 458 (2004).
17. G. Mendonca, D. B. Mendonca, F. J. Aragao, and L. F. Cooper, Advancing dental implant surface technology-from micron-to nanotopography. Biomaterials 29, 3822 (2008).
18. G. Mundy, R. Garrett, S. Harris, J. Chan, D. Chen, G. Rossini, B. Boyce, M. Zhao, and G. Gutierrez, Stimulation of bone formation in vitro and in rodents by statins. Science 286, 1946 (1999).
19. R. Narayanan, S. K. Seshadri, T. Y. Kwon, and K. H. Kim, Calcium phosphate-based coatings on titanium and its alloys. J. Biomed. Mater. Res. B Appl. Biomater. 85, 279 (2008).
20. H. Oxlund, M. Dalstra, and T. T. Andreassen, Statin given perorally to adult rats increases cancellous bone mass and compressive strength. Calcif Tissue Int. 69, 299 (2001).
21. S. Ruiz-Gaspa, X. Nogues, A. Enjuanes, J. C. Monllau, J. Blanch, R. Carreras, L. Mellibovsky, D. Grinberg, S. Balcells, A. Diez-Perez, and others, Simvastatin and atorvastatin enhance gene expression of collagen type 1 and osteocalcin in primary human osteoblasts and MG-63 cultures. J. Cell Biochem. 101, 1430 (2007).
22. M. Sato, A. Aslani, M. A. Sambito, N. M. Kalkhoran, E. B. Slamovich, and T. J. Webster, Nanocrystalline hydroxyapatite/titania coatings on titanium improves osteoblast adhesion. J. Biomed. Mater. Res. A 84, 265 (2008).
23. C. Song, Z. Guo, Q. Ma, Z. Chen, Z. Liu, H. Jia, and G. Dang, Simvastatin induces osteoblastic differentiation and inhibits adipocytic differentiation in mouse bone marrow stromal cells. Biochem. Biophys. Res. Commun. 308, 458 (2003).
24. G. L. Wu, H. L. Zhou, J. Z. Shentu, Q. J. He, and B. Yang, Determination of lansoprazole in human plasma by rapid resolution liquid chromatography- electrospray tandem mass spectrometry: Application to a bioequivalence study on Chinese volunteers. J. Pharm. Biomed. Anal. 48, 1485 (2008).
25. Y. Wu, J. P. Zitelli, K. S. TenHuisen, X. Yu, and M. R. Libera, Differential response of staphylococci and osteoblasts to varying titanium surface roughness. Biomaterials 32, 951 (2011).
26. F. Yang, S. F. Zhao, F. Zhang, F. M. He, and G. L. Yang, Simvastatin-loaded porous implant surfaces stimulate preosteoblasts differentiation: An in vitro study. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 111, 551 (2011).
27. G. L. Yang, F. M. He, J. A. Hu, X. X. Wang, and S. F. Zhao, Biomechanical comparison of biomimetically and electrochemically deposited hydroxyapatite-coated porous titanium implants. J. Oral Maxillofac. Surg. 68, 420 (2010).
28. G. L. Yang, F. M. He, J. A. Hu, X. X. Wang, and S. F. Zhao, Effects of biomimetically and electrochemically deposited nanohydroxyapatite coatings on osseointegration of porous titanium implants. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 107, 782 (2009).
29. G. L. Yang, F. M. He, E. Song, J. A. Hu, X. X. Wang, and S. F. Zhao, In vivo comparison of bone formation on titanium implant surfaces coated with biomimetically deposited calcium phosphate or electrochemically deposited hydroxyapatite. Int. J. Oral Maxillofac. Implants 25, 669 (2010).
30. Y. Zou, J. L. Brooks, V. Talwalkar, T. A. Milbrandt, and D. A. Puleo, Development of an injectable two-phase drug delivery system for sequential release of antiresorptive and osteogenic drugs. J. Biomed. Mater. Res. B Appl. Biomater 100, 155 (2012).